Save time and jump to the most important pieces.
4 - Envoy Medical, Inc. (0001840877) (Issuer)
Anzu Special Acquisition Corp I (the "Company") (NASDAQ: "ANZU," "ANZUU" and "ANZUW"), announced today that its stockholders voted to approve the Business Combination Agreement with Envoy Medical Corporation ("Envoy"), and the transactions contemplated thereby (the "Business Combination") at the Company's special meeting of stockholders held on September 27, 2023 (the "Special Meeting"). Pursuant to the Business Combination Agreement, Merger Sub will merge with and into Envoy, with Envoy surviving the merger as a wholly owned subsidiary of the Company (the "Merger"). Following the closing of the Merger (the "Closing"), the Company will be renamed "Envoy Medical, Inc.", which is referred t
Anzu Special Acquisition Corp I (the "Company") (NASDAQ: "ANZU," "ANZUU" and "ANZUWS"), announced today that it convened and then adjourned, without conducting any other business, the Company's special meeting of stockholders (the "Special Meeting") held on February 9, 2023. The Special Meeting has been adjourned until 9:30 a.m., Eastern time, on February 21, 2023 (the "Adjourned Special Meeting"). The Adjourned Special Meeting will be held virtually via live webcast at https://web.lumiagm.com/274911563. The record date remains the close of business, Eastern Time, on January 17, 2023. At the Adjourned Special Meeting, stockholders will be asked to vote on a proposal to amend the Company's
SC 13G/A - Envoy Medical, Inc. (0001840877) (Subject)
SC 13G/A - Anzu Special Acquisition Corp I (0001840877) (Subject)
SC 13G - Anzu Special Acquisition Corp I (0001840877) (Subject)
S-1/A - Envoy Medical, Inc. (0001840877) (Filer)
S-1 - Envoy Medical, Inc. (0001840877) (Filer)
10-Q/A - Envoy Medical, Inc. (0001840877) (Filer)
4/A - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
4 - Envoy Medical, Inc. (0001840877) (Issuer)
During Thursday's session, 406 companies made new 52-week lows. Key Facts About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE). The smallest company by market cap to set a new 52-week low was Ascent Solar Technologies (NASDAQ:ASTI). Ascent Solar Technologies (NASDAQ:ASTI)'s stock fell the most, as it traded down 62.52% to reach a new 52-week low. Nuveen Pennsylvania (NYSE:NQP)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low. Stocks that set new 52-week lows on Thursday are as follows: Pfizer (NYSE:PFE) stock hit $31.77 on Thursday morning, setting a new 52-week low for a change of do
Gainers Bionomics Limited (NASDAQ:BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Baudax Bio, Inc. (NASDAQ:BXRX) gained 109% to $0.6287 after the company announced it was granted orphan drug designation by the FDA for TI-168 for the treatment of Hemophilia A with inhibitors. Chico's FAS, Inc. (NYSE:CHS) shares climbed 61.7% to $7.45 following the announcement of its acquisition by Sycamore Partners for $1 billion. Aditxt, Inc. (NASDAQ:ADTX) gained 57% to $20.47. Axcella Health Inc. (NASDAQ:AXLA) rose 31.3% to $9.08.
Anzu Special Acquisition Corp I (the "Company") (NASDAQ: "ANZU," "ANZUU" and "ANZUW"), announced today that its stockholders voted to approve the Business Combination Agreement with Envoy Medical Corporation ("Envoy"), and the transactions contemplated thereby (the "Business Combination") at the Company's special meeting of stockholders held on September 27, 2023 (the "Special Meeting"). Pursuant to the Business Combination Agreement, Merger Sub will merge with and into Envoy, with Envoy surviving the merger as a wholly owned subsidiary of the Company (the "Merger"). Following the closing of the Merger (the "Closing"), the Company will be renamed "Envoy Medical, Inc.", which is referred to